Skip to the page

Data / Form D filings / Sarentis Therapeutics Inc

Sarentis Therapeutics Inc: Form D filings

Sarentis Therapeutics Inc, a pharmaceuticals company in New York, NY, filed 2 Form D notices with the SEC between 2009 and 2015. The latest, on July 8, 2015, reports $750,000 sold of a $1 million offering to 1 investor.

Find out what Sarentis Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
70 E 77TH ST APT 9C, New York, NY, 10021
Phone
(212) 861-6348
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1477584

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 8, 2015New notice$1,000,000$750,000$250,0001Jun 24, 2015sec.gov
Nov 25, 2009New notice$3,609,654$3,609,654$05Nov 10, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Denise BarbutExecutive Officer, Director, Promoter

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of Jul 6, 2015 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Sarentis Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.